ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: L01

Outcomes of COVID-19 Infection in Patients with Rheumatic Diseases in a Multicenter Healthcare System: A Comparative Cohort Study

Naomi Serling-Boyd1, Kristin D'Silva1, Tiffany Hsu2, Xiaoqing Fu3, Rachel Wallwork4, April Jorge1, Yuqing Zhang1, Ellen Gravallese5, Hyon K. Choi6, Jeffrey Sparks7 and Zachary Wallace8, 1Massachusetts General Hospital, Boston, MA, 2Brigham and Women's Hospital, Jamaica Plain, MA, 3Mass General Hospital, Boston, MA, 4Johns Hopkins Hospital, Baltimore, MA, 5Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 6MASSACHUSETTS GENERAL HOSPITAL, Lexington, MA, 7Brigham and Women's Hospital, Boston, MA, 8Massachusetts General Hospital, Newton, MA

Meeting: ACR Convergence 2020

Date of first publication: October 23, 2020

Keywords: Cohort Study, COVID-19, Late-Breaking 2020, Outcome measures

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Date: Monday, November 9, 2020

Session Title: Late-Breaking Posters

Session Type: Poster Session D

Session Time: 9:00AM-11:00AM

Background/Purpose: The risk of poor outcomes from COVID-19 among rheumatic disease patients compared to the general population remains poorly understood. Filling this knowledge gap is a high priority for patients and providers. We previously observed a higher risk of mechanical ventilation in patients with rheumatic diseases compared to the general population in a small cohort study early in the pandemic.

Methods: We conducted a cohort study of COVID-19 patients (confirmed by polymerase chain reaction [PCR]) between January 30 and July 16, 2020, at a multicenter healthcare system including academic and community hospitals and longitudinal clinics. We compared each patient with systemic rheumatic disease to up to 5 matched (by age, sex, and date of COVID-19 PCR) comparators without rheumatic disease. In our primary analysis, we used multivariable Cox proportional hazard regression to estimate hazard ratios (HR) and 95% confidence intervals (CI) for COVID-19 outcomes, comparing patients with and without rheumatic disease and adjusting for potential confounders. Outcomes were evaluated through end of follow-up in the system or August 18, 2020. To further evaluate temporal trends in mechanical ventilation among rheumatic disease patients, we compared risk of this outcome in an early vs. recent cohort (PCR testing before vs. after the midpoint among rheumatic disease patients) using similar methods.

Results: We identified 143 rheumatic disease patients (mean age 60 years, 76% female) and 688 matched comparators (mean age 59 years, 76% female) out of 16,211 patients who had confirmed COVID-19 (Table 1). Median Charlson Comorbidity Index (CCI) scores and interquartile range (IQRs) were higher among patients with rheumatic disease (2 [IQR: 1, 4]) vs. comparators (0 [IQR: 0, 2]). The most common rheumatic diseases were rheumatoid arthritis (44, 31%) and systemic lupus erythematosus (27, 19%) (Table 2). Fifty-one (36%) rheumatic disease patients were on glucocorticoids, 30 (21%) were on hydroxychloroquine, 41 (29%) were on at least 1 biologic disease-modifying antirheumatic drug (DMARD), and 44 (31%) were on at least 1 conventional synthetic DMARD. Patients with rheumatic disease had higher unadjusted risk of mechanical ventilation than comparators (unadjusted HR 1.75, 95% CI: 1.12 to 2.74) (Table 3). After adjustment for race, smoking, and CCI, there were no significantly higher risks of hospitalization (HR 0.87, 95% CI: 0.68 to 1.11), intensive care unit admission (HR 1.27, 95% CI: 0.86 to 1.86), mechanical ventilation (HR 1.51, 95% CI: 0.93 to 2.44), or death (HR 1.02, 95% CI: 0.53 to 1.95) in rheumatic disease patients vs. comparators. We observed a trend toward improvement in the risk of mechanical ventilation in the recent vs. early rheumatic disease cohorts (10% vs. 19%, adjusted HR 0.44, 95% CI: 0.17 to 1.12).

Conclusion: Patients with rheumatic disease had similar risk of severe COVID-19 outcomes vs. comparators. There was a temporal trend toward improvement in risk of mechanical ventilation for rheumatic disease patients. These findings provide reassurance for rheumatic disease patients but close monitoring of rheumatic disease patients with other comorbidities is warranted.

Table 1. Clinical characteristics of patients with systemic rheumatic disease with COVID-19 infection (N=143) and matched comparators (N=688) at the time of COVID-19 infection diagnosis.

Table 2. Details of rheumatic disease diagnosis and management at the time of COVID-19 diagnosis (N=143).

Table 3. COVID-19 outcomes in patients with systemic rheumatic disease (N=143) versus matched comparators (N=688).


Disclosure: N. Serling-Boyd, None; K. D'Silva, None; T. Hsu, None; X. Fu, None; R. Wallwork, None; A. Jorge, None; Y. Zhang, None; E. Gravallese, Rheumatology Textbook, 7; H. Choi, AstraZeneca, 2, Takeda, 5, Selecta, 5, GlaxoSmithKline, 5, Horizon, 5; J. Sparks, Amgen, 2, Bristol-Myers Squibb, 2, 5, Gilead, 5, Inova, 5, Janssen, 5, Optum, 5; Z. Wallace, Viela Bio, 5, Bristol-Myers Squibb, 2.

To cite this abstract in AMA style:

Serling-Boyd N, D'Silva K, Hsu T, Fu X, Wallwork R, Jorge A, Zhang Y, Gravallese E, Choi H, Sparks J, Wallace Z. Outcomes of COVID-19 Infection in Patients with Rheumatic Diseases in a Multicenter Healthcare System: A Comparative Cohort Study [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/outcomes-of-covid-19-infection-in-patients-with-rheumatic-diseases-in-a-multicenter-healthcare-system-a-comparative-cohort-study/. Accessed January 24, 2021.
  • Tweet
  • Email
  • Print
Save to PDF

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/outcomes-of-covid-19-infection-in-patients-with-rheumatic-diseases-in-a-multicenter-healthcare-system-a-comparative-cohort-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.